WISCONSIN (WAOW) — The Wisconsin Department of Health Services is instructing vaccine providers to stop administering Johnson & Johnson COVID-19 vaccine.
This instruction comes after the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended a "pause" in administration of the single-dose vaccine while officials investigate rare and severe blood clots.
“We are pausing administration of the Johnson & Johnson vaccine out of an abundance of caution. At this time, these adverse events appear to be extremely rare,” said DHS Secretary-designee Karen Timberlake. “Vaccine providers should not administer the Johnson & Johnson vaccine at this time, and should hold on to the vaccine until federal review has been completed.”
Providers will still store vaccine and report any adverse reaction to the State.
According to DHS, the pause allows the CDC to determine further cases of the clotting suborder and provide guidance to health care providers.
Pfizer and Moderna vaccines are not impacted by the pause in administration.
“So far, there have been no reports of cerebral venous sinus thrombosis with low platelets in anyone who has received one of the mRNA (Pfizer and Moderna) vaccines,” said Dr. Westergaard. “The FDA, CDC, and DHS continue to recommend the use of the Pfizer and Moderna vaccines at this time, while the adverse events related to the Johnson & Johnson vaccine continue to be investigated.”
DHS says those who have gotten the Johnson & Johnson vaccine should monitor for the following symptoms for three weeks after vaccination:
- Severe headache
- Abdominal pain
- Leg pain
- Shortness of breath
This is a developing story. Stick with News 9 as more information becomes available.